Search Results 1-10 of 15295 for Alirocumab
Alirocumab injection is used together with a proper diet and other medicines (eg, ezetimibe, statin medicine) to treat patients with primary hyperlipidemia ( ...
This medicine is given as a shot under your skin, usually in the stomach, thighs, or upper arms. Alirocumab may sometimes be given at home to patients who do ...
Chest pain or tightness · difficulty with breathing or swallowing · fast heartbeat · fever · hives, itching, skin rash · hoarseness · irritation · joint pain, ...
It is very important that your doctor check your progress within 4 to 8 weeks of using this medicine. This will allow your doctor to see if the medicine is ...
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of alirocumab injection in the elderly.
Study of Alirocumab (REGN727/SAR236553) in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) Undergoing Low-density Lipoprotein (LDL) Apheresis ...
One approach has been to target biochemical pathways that impact LDL receptor availability. The human monoclonal antibodies evolocumab and alirocumab work by ...
Antisense oligonucleotide to ApoB (mipomersen); Microsomal triglyceride transfer protein (lomitapide); Monoclonal antibodies to PCSK9 (alirocumab, evolocumab).
These newer drugs — alirocumab (Praluent) and evolocumab (Repatha) — help the liver absorb more LDL cholesterol, which lowers the amount of cholesterol ...
Alirocumab (Praluent) Evolocumab (Repatha), Decrease LDL ; usually reserved for people who have a genetic condition that causes very high LDL levels or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.